Your valuation sets the ownership an investor buys. Pair it with a return target and a dilution assumption, and you can calculate the exit value that would produce that return.

If you are preparing a raise, work through that calculation before you defend the price. It gives you a concrete question to answer with the market, traction and team slides in your deck.

Look at what happens when you do the same arithmetic yourself.

What startup valuation investors check before they discuss the number

For a simple priced round, post-money valuation equals pre-money valuation plus new investment. Ownership calculations also need to account for the actual cap table, including options and converting instruments. Carta explains the fully diluted calculation and how to model the round.

Imagine a hypothetical Berlin company selling workflow software to logistics teams. It asks for $3M at a $9M pre-money valuation, so the post-money is $12M and the round buys 25%.

That's the founder's version: a price, a check size, a percentage. The investor's version starts one step later.

First pass: the associate back-solves the price

In this hypothetical review, an associate starts with the ask and works out the exit that would meet the fund's assumed return target. This is a way to test your deck, rather than a claim that every investor follows the same sequence.

In this hypothetical example, the fund wants this check to return 10x. Suppose also that later rounds dilute the 25% to 15% by exit. Ten times $3M is $30M, and $30M divided by 15% is a $200M exit.

Under those assumptions, the required exit is $200M. That is a scenario to test, rather than a prediction of what the company will sell for. The associate checks whether the market and growth evidence make that outcome plausible.

Second pass: the partner has to repeat the story

Continue the hypothetical review with a partner preparing to discuss the investment with colleagues. She needs to explain the company and the return case without walking everyone through the whole deck.

What she repeats is short: what the company does, why this team, why now, and what it becomes. If the exit is missing from that retelling, the price has nothing holding it up in the one conversation where the money gets decided.

Third pass: diligence tests the evidence

Now the numbers get checked against the claims. Customer calls, cohort data and the financial model all get opened, and each one is read against a slide you wrote weeks earlier. What investors need to see in a startup financial model covers what that pass looks for.

A gap between slide and spreadsheet gives an investor another claim to check. Explain the difference and correct it before a reader has to ask.

What a miss costs

In a hypothetical first call, the associate asks you to trace the market figure. You discover that it includes buyers your product cannot serve, so you have to narrow it while explaining why your valuation still holds. Preparing the bottom-up calculation would have given you that answer before the meeting.

How investors justify a startup valuation to their own partners

To prepare for a valuation discussion, set your comparable-company evidence alongside an explicit return scenario. A comparable price can support the negotiation, while the scenario shows what the investor would need to believe about your company.

The reason is a path from where the company stands today to an outcome big enough to pay for the fund's other losses. Return multiple expectations differ from fund to fund, and your deck can't know the one in the room. It can make the path visible, so the investor can run her own multiple through it.

The methods behind the price, from comparables to scorecards, are covered in our startup valuation breakdown. This piece starts where those end, with the question of who has to believe the number and what they need to see.

Valuation vs. ownership and dilution in a funding round

Founders negotiate a price. Investors negotiate what they'll own when the company exits.

Take a hypothetical Bangalore consumer app raising the same $3M, but at a $12M pre-money. The post-money is $15M and the investor buys 20% instead of 25%. Assume the same proportional dilution as before, so 60% of the stake survives to exit and 20% becomes 12%.

In this hypothetical comparison, $30M divided by 12% is a $250M exit. The founder kept five more points of the company, and the deck owes the reader an exit $50M larger.

With the same investment, dilution and return target, a higher pre-money valuation implies a larger required exit. The question is whether your market slide, your traction curve and your team page can carry that promise, because the investor will test each one against it.

Is a lower valuation better for raising a seed round?

A lower price shrinks the exit the investor needs to believe in, but it sells more of the company and sets the number the next investor starts from. The better price is the highest one your evidence can carry through the back-solve.

That's a narrower target than it sounds. A price below what the evidence supports leaves ownership on the table, and a price above it hands the associate a reason to ask questions you can't answer.

What investors underwrite beyond valuation

For startup valuation investors, the return case is one layer. Underneath it, the investor is underwriting a team, a set of risks, and a story a partner can repeat.

Founder-market fit is the part of the team judgment a deck can show. Imagine a hypothetical London founder who spent years running risk reviews at a bank and now sells compliance software to banks. Her team slide makes the exit more plausible than any comparable could, because the investor can see why she'd win the first ten customers.

The risk side works the same way. Showing your churn calculation gives the investor something to examine. State the measurement period and explain the changes. It can still prompt questions, but you have supplied the evidence needed to discuss them.

Use your traction slide to test the exit scenario against the growth you can actually demonstrate. Which traction metrics belong in a pitch deck and why shows how to choose the figures that carry it.

Objections are what's left when the evidence runs out. How to answer investor objections before they stall the next meeting is useful because each objection points at a slide that didn't finish its job.

How do I defend my valuation to investors in a pitch meeting?

Walk the investor through the exit your price requires, then point to the slides that make it believable. Start with the number the associate would back-solve anyway, so you're the one who says it first.

That changes the meeting. You aren't arguing with a figure. You're showing a reader the market sizing and the traction curve that put a $200M outcome within reach, or admitting plainly where the evidence is thinner and the price reflects it.

Run the back-solve before they do

Write one sentence about your own raise: at this post-money, the investor owns this much, so the company has to exit for this much, and these three slides are the evidence. Use your own dilution assumption and say what it is.

Then read your deck as the associate would, with that sentence next to it. Where a slide doesn't support the exit, you've found the question you'll be asked, and you still have time to answer it on the page. The audit kit is one way to run that pass slide by slide.

Upload your deck for Deckmetric's pitch analysis, then compare the feedback with the return scenario you have written. Check the market and financial assumptions yourself before using them in a fundraising discussion.

Valuation is not the story investors are actually underwriting